Median levels of copeptin were higher in subjects with T2D (10.8 (7.8; 15.2) pmol/l) compared to prediabetes (9.1 (6.4; 12.6) pmol/l) and NGT (8.6 (5.9; 11.4) pmol/l) (Table 1). The gene discussed is AVP; the disease is prediabetes syndrome.